 |
Vaughn
M. Kailian became Co-chairman of the Board of Directors of
Millennium Pharmaceuticals, Inc. in February 2002, following
Millennium's acquisition of COR Therapeutics, Inc. where he
had served as CEO, President and Director since March 1990.
Mr. Kailian is a member of the Pharmaceutical Foundation Advisory Council at the University of Texas at Austin and the University of Florida.
He is a Director of Amylin Pharmaceuticals, Inc., the Biotechnology Industry Organization (BIO) and Chairman of the California Health Care Institute.
After graduating from Tufts University, Mr. Kailian was employed by Marion Merrell Dow, Inc., a pharmaceutical company, and its predecessor companies, in various international and U.S. management, marketing and sales positions from 1967 to 1990, including General Manager, Merrell Dow USA, and President and Corporate Vice President of Global Commercial Development, Marion Merrell Dow, Inc. |
|